Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
Conditions
Interventions
ubenimex
placebo
Locations
31
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
California Heart Center Foundation, An Affiliate of Cedars-Sinai Heart Institute, Cedars-Sinai Medical Care Foundation
Beverly Hills, California, United States
UCSD Medical Center
La Jolla, California, United States
Stanford University Medical Center
Stanford, California, United States
University of Colorado Denver
Aurora, Colorado, United States
University of Florida
Gainesville, Florida, United States
Start Date
April 1, 2016
Primary Completion Date
November 1, 2017
Completion Date
January 1, 2018
Last Updated
March 6, 2023
NCT07120789
NCT07218029
NCT06649110
NCT04778046
NCT06481852
NCT06477640
Lead Sponsor
Eiger BioPharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions